Reset Map3 Results
628 NJ-10 Suite 10 WHIPPANY, New Jersey, 07981 United StatesAxela Biosciences, Inc.—formed through the merger of PicoImmune and Emerther in July 2024—is a specialized CRO offering ultra-sensitive, highly multiplexed, and reliable bioanalytical services. We empower drug discovery and translational research through precise, real-time monitoring of protein and gene expression in minute samples from cells, tissues, animal models, and patient-derived specimens. Our core capabilities include ultra-sensitive immunoassays using platforms such as SIMOA, MSD, Luminex, and Simple Western; spatial transcriptomics and proteomics using the NanoString GeoMx DSP; and multiplex biomarker discovery using FPPA, RPPA, and FlexMAP 3D technologies. We also provide high-throughput, multi-color flow cytometry with CytoFLEX S systems, genomic profiling through NanoString nCounter Pro and real-time qPCR, and advanced imaging using systems like IncuCyte and EVOS FL Auto. With automated liquid handling and flexible assay development workflows, we support a wide range of custom study needs. We routinely work with human and animal samples, including mouse and rat models, and analyze PBMCs, whole blood, plasma, serum, FFPE and fresh-frozen tissues, as well as cultured cells and cell lysates. What sets Axela apart is our dual strength in immunoassays and spatial omics, our deep experience supporting top pharmaceutical, biotech, and academic partners, and our highly trained team of scientists with backgrounds from MIT, Harvard, NIH, MSKCC, NYU, Duke, and other leading institutions. Our team combines technical rigor with real-world biopharma experience to deliver responsive project execution, high-throughput capacity, and rapid turnaround times. We operate under CLIA-compliant protocols, follow validated SOPs, and offer workflows compatible with human sample handling and IRB-exempt studies. Our infrastructure includes more than 30 advanced instruments, such as NanoString GeoMx DSP and nCounter Pro (two units each), CytoFLEX S flow cytometers, SIMOA and MSD QuickPlex systems, Simple Western units, Luminex 200 and FlexMAP 3D platforms, EVOS FL Auto and IncuCyte live-cell imaging systems, ABI QuantStudio qPCR machines, an ELISpot reader, ECIS platform, and other high-throughput tools. Full instrumentation details are available in our profile. We welcome collaborations through Scientist.com. To learn more or discuss your project directly, you can schedule a meeting at https://calendly.com/david-huang-axelabio/30min or send an email to harris.zhang@axelabio.com (CSO) or david.huang@axelabio.com (Business Development Manager)
622 Route-10 West Unit 18 Whippany, NJ, 07981 United StatesAxela Biosciences, Inc.—formed through the merger of PicoImmune and Emerther in July 2024—is a specialized CRO offering ultra-sensitive, highly multiplexed, and reliable bioanalytical services. We empower drug discovery and translational research through precise, real-time monitoring of protein and gene expression in minute samples from cells, tissues, animal models, and patient-derived specimens. Our core capabilities include ultra-sensitive immunoassays using platforms such as SIMOA, MSD, Luminex, and Simple Western; spatial transcriptomics and proteomics using the NanoString GeoMx DSP; and multiplex biomarker discovery using FPPA, RPPA, and FlexMAP 3D technologies. We also provide high-throughput, multi-color flow cytometry with CytoFLEX S systems, genomic profiling through NanoString nCounter Pro and real-time qPCR, and advanced imaging using systems like IncuCyte and EVOS FL Auto. With automated liquid handling and flexible assay development workflows, we support a wide range of custom study needs. We routinely work with human and animal samples, including mouse and rat models, and analyze PBMCs, whole blood, plasma, serum, FFPE and fresh-frozen tissues, as well as cultured cells and cell lysates. What sets Axela apart is our dual strength in immunoassays and spatial omics, our deep experience supporting top pharmaceutical, biotech, and academic partners, and our highly trained team of scientists with backgrounds from MIT, Harvard, NIH, MSKCC, NYU, Duke, and other leading institutions. Our team combines technical rigor with real-world biopharma experience to deliver responsive project execution, high-throughput capacity, and rapid turnaround times. We operate under CLIA-compliant protocols, follow validated SOPs, and offer workflows compatible with human sample handling and IRB-exempt studies. Our infrastructure includes more than 30 advanced instruments, such as NanoString GeoMx DSP and nCounter Pro (two units each), CytoFLEX S flow cytometers, SIMOA and MSD QuickPlex systems, Simple Western units, Luminex 200 and FlexMAP 3D platforms, EVOS FL Auto and IncuCyte live-cell imaging systems, ABI QuantStudio qPCR machines, an ELISpot reader, ECIS platform, and other high-throughput tools. Full instrumentation details are available in our profile. We welcome collaborations through Scientist.com. To learn more or discuss your project directly, you can schedule a meeting at https://calendly.com/david-huang-axelabio/30min or send an email to harris.zhang@axelabio.com (CSO) or david.huang@axelabio.com (Business Development Manager)
628 NJ-10 Suite 10 WHIPPANY, NJ, 07981 United StatesAxela Biosciences, Inc.—formed through the merger of PicoImmune and Emerther in July 2024—is a specialized CRO offering ultra-sensitive, highly multiplexed, and reliable bioanalytical services. We empower drug discovery and translational research through precise, real-time monitoring of protein and gene expression in minute samples from cells, tissues, animal models, and patient-derived specimens. Our core capabilities include ultra-sensitive immunoassays using platforms such as SIMOA, MSD, Luminex, and Simple Western; spatial transcriptomics and proteomics using the NanoString GeoMx DSP; and multiplex biomarker discovery using FPPA, RPPA, and FlexMAP 3D technologies. We also provide high-throughput, multi-color flow cytometry with CytoFLEX S systems, genomic profiling through NanoString nCounter Pro and real-time qPCR, and advanced imaging using systems like IncuCyte and EVOS FL Auto. With automated liquid handling and flexible assay development workflows, we support a wide range of custom study needs. We routinely work with human and animal samples, including mouse and rat models, and analyze PBMCs, whole blood, plasma, serum, FFPE and fresh-frozen tissues, as well as cultured cells and cell lysates. What sets Axela apart is our dual strength in immunoassays and spatial omics, our deep experience supporting top pharmaceutical, biotech, and academic partners, and our highly trained team of scientists with backgrounds from MIT, Harvard, NIH, MSKCC, NYU, Duke, and other leading institutions. Our team combines technical rigor with real-world biopharma experience to deliver responsive project execution, high-throughput capacity, and rapid turnaround times. We operate under CLIA-compliant protocols, follow validated SOPs, and offer workflows compatible with human sample handling and IRB-exempt studies. Our infrastructure includes more than 30 advanced instruments, such as NanoString GeoMx DSP and nCounter Pro (two units each), CytoFLEX S flow cytometers, SIMOA and MSD QuickPlex systems, Simple Western units, Luminex 200 and FlexMAP 3D platforms, EVOS FL Auto and IncuCyte live-cell imaging systems, ABI QuantStudio qPCR machines, an ELISpot reader, ECIS platform, and other high-throughput tools. Full instrumentation details are available in our profile. We welcome collaborations through Scientist.com. To learn more or discuss your project directly, you can schedule a meeting at https://calendly.com/david-huang-axelabio/30min or send an email to harris.zhang@axelabio.com (CSO) or david.huang@axelabio.com (Business Development Manager)
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.